|
|
Biomark Diagnostics Inc
CSE •
Healthcare •
Diagnostics & Research •
Quote as of 08/24/2026 15:44
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeCSE
Market Capitalization57.8 mln
Earnings Date07/09/2025
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS-0.01
ROE-254
ROIC-233
ROA-79.53
EBITDA, mln-1.10
EV / EBITDA-52.21
EV / EBIT-34.66
Revenue, mln0.09
EV / Revenue622
Financial Strength
Altman Z-Score7.76
Piotroski F-Score
4
/ 9
Beneish M-Score-0.16
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-9.09% |
19
/ 100
 |
| 1 Month |
-7.41% |
35
/ 100
 |
| 2 Months |
-15.25% |
51
/ 100
 |
| 6 Months |
2.04% |
72
/ 100
 |
| 1 Year |
78.57% |
80
/ 100
 |
|
| |
